A Global Perspective of Latent Autoimmune Diabetes in Adults: Trends in Endocrinology & Metabolism
Should anti-glutamic acid decarboxylase antibody levels be determined in new-onset diabetes? - Endocrine Practice
Adult-onset autoimmune diabetes: comparative analysis of classical and latent presentation | Diabetology & Metabolic Syndrome | Full Text
Anti-thyroid peroxidase antibody, IA-2 antibody, and fasting C-peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA)—A 5-year follow-up of the Ehime study - ScienceDirect
Endocrinology and Metabolism
Masquerading as Type 2 DM: - ppt download
Anti-thyroid peroxidase antibody, IA-2 antibody, and fasting C-peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA)—A 5-year follow-up of the Ehime study - ScienceDirect
Urinary C-Peptide Creatinine Ratio as a Non-Invasive Tool for Identify | DMSO
Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients - Kidney International
EASD 2021: Reconciling the International Consensus Reports for LADA and Type 1. Part 1: Diagnosis – The Practical Diabetic
LADA Diagnosis and Management - Diabetes Qualified
The C-Peptide Test – The Most Important Blood Test for Diabetes
Mean C-peptide levels in different types of diabetes. Black circle:... | Download Scientific Diagram
The Gold Standard for Treating Type 1 LADA (And Fighting To Be Recognized) – The Practical Diabetic
Mean C-peptide levels in different types of diabetes. Black circle:... | Download Scientific Diagram
Management of Latent Autoimmune Diabetes in Adults
The C-Peptide Test – The Most Important Blood Test for Diabetes
Prevalence and identification of type 1 diabetes in Chinese adults wit | DMSO
Latent autoimmune diabetes in adults LADA What do primary care professionals need toknow - PCDS
The Gold Standard for Treating Type 1 LADA (And Fighting To Be Recognized) – The Practical Diabetic
Insulin secretion in patients with latent autoimmune diabetes (LADA): half way between type 1 and type 2 diabetes: action LADA 9 | BMC Endocrine Disorders | Full Text